Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1973 Dec;4(6):589–592. doi: 10.1128/aac.4.6.589

Pharmacokinetics of Cephanone in Healthy Adult Volunteers

Claude Regamey 1, William M M Kirby 1
PMCID: PMC444601  PMID: 4793878

Abstract

Five volunteers received intramuscular injections of 7 mg (approximately 500 mg) of cephanone, a new cephalosporin for parenteral use per kg. Peak serum concentrations averaged 36 μg/ml, about four times as high as with the same doses of cephalothin, twice as high as with cephaloridine, and slightly lower than with cefazolin. With a constant intravenous infusion of 100 mg/h, a steady-state serum concentration of 31 μg/ml was attained in four volunteers. The serum half-life was similar for the intramuscular and intravenous studies, 2.4 and 2.6 h, respectively. Over 90% of the dose administered was recovered in the urine. The factor mainly responsible for the higher and more sustained serum concentrations of cephanone was its low renal clearance of 47 ml per min per 1.73 m2. Cephanone has a small apparent volume of distribution, probably related to its high serum protein binding of 88%.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benner E. J., Brodie J. S., Kirby W. M. Laboratory and clinical comparison of cephaloridine and cephalothin. Antimicrob Agents Chemother (Bethesda) 1965;5:888–893. [PubMed] [Google Scholar]
  2. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett J. V., Kirby W. M. A rapid, modified ultrafiltration method for determining serum protein binding and its application to new penicillins. J Lab Clin Med. 1965 Nov;66(5):721–732. [PubMed] [Google Scholar]
  4. KLEIN J. O., EICKHOFF T. C., TILLES J. G., FINLAND M. CEPHALOTHIN: ACTIVITY IN VITRO, ABSORPTION AND EXCRETION IN NORMAL SUBJECTS AND CLINICAL OBSERVATIONS IN 40 PATIENTS. Am J Med Sci. 1964 Dec;248:640–656. [PubMed] [Google Scholar]
  5. Kabins S. A., Cohen S. Cephaloridine therapy as related to renal function. Antimicrob Agents Chemother (Bethesda) 1965;5:922–932. [PubMed] [Google Scholar]
  6. Kirby W. M., De Maine J. B., Serrill W. S. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. Postgrad Med J. 1971 Feb;47(Suppl):41–46. [PubMed] [Google Scholar]
  7. Meyers B. R., Hirschman S. Z., Nicholas P. Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers. Antimicrob Agents Chemother. 1972 Oct;2(4):250–254. doi: 10.1128/aac.2.4.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Shibata K., Fujii M. Clinical studies of cefazolin in the surgical field. Antimicrob Agents Chemother (Bethesda) 1970;10:467–472. [PubMed] [Google Scholar]
  9. Tuano S. B., Brodie J. L., Kirby W. M. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration. Antimicrob Agents Chemother (Bethesda) 1966;6:101–106. [PubMed] [Google Scholar]
  10. Tuano S. B., Johnson L. D., Brodie J. L., Kirby W. M. Comparative blood levels of hetacillin, ampicillin and penicillin G. N Engl J Med. 1966 Sep 22;275(12):635–639. doi: 10.1056/NEJM196609222751203. [DOI] [PubMed] [Google Scholar]
  11. Wick W. E., Preston D. A. Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics. Antimicrob Agents Chemother. 1972 Mar;1(3):221–234. doi: 10.1128/aac.1.3.221. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES